SANOFI (SAN.PA) Stock Price, Forecast & Analysis
Europe • Euronext Paris • EPA:SAN • FR0000120578
SAN.PA Key Statistics, Chart & Performance
The current stock price of SAN.PA is 80.36 EUR. In the past month the price decreased by -4.83%. In the past year, price decreased by -22.25%.
SAN.PA Technical Analysis
SAN.PA Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to SAN.PA. SAN.PA has a medium profitability rating, but doesn't score so well on its financial health evaluation.
SAN.PA Financial Highlights
Over the last trailing twelve months SAN.PA reported a non-GAAP Earnings per Share(EPS) of 7.82. The EPS increased by 1.82% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 20.63% | ||
| ROA | 10.63% | ||
| ROE | 18.84% | ||
| Debt/Equity | 0.18 |
SAN.PA Forecast & Estimates
29 analysts have analysed SAN.PA and the average price target is 100.14 EUR. This implies a price increase of 24.61% is expected in the next year compared to the current price of 80.36.
For the next year, analysts expect an EPS growth of 8.1% and a revenue growth 6.49% for SAN.PA
SAN.PA Ownership
SAN.PA Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| 1SAN | SANOFI | 9.69 | 197.812B | ||
| SNW | SANOFI | 9.5 | 193.899B | ||
| 1MRK | MERCK KGAA | 14.2 | 55.739B | ||
| MRK | MERCK KGAA | 14.13 | 52.804B | ||
| UNC | UCB SA | 25.52 | 51.039B | ||
| UCB | UCB SA | 25.48 | 50.962B | ||
| BAYN | BAYER AG-REG | 9.37 | 44.995B | ||
| 1BAYN | BAYER AG-REG | 9.17 | 44.008B | ||
| IPN | IPSEN | 11.93 | 11.406B |
Related stock screener links
View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the Euronext Paris Exchange | Find stocks with similar TA and Setup ratings on the EuroNext exchanges | Find stocks with similar Fundamental rating on the EuroNext exchanges | Find the competitors with the best technical ratings on the EuroNext exchanges | Find the competitors with the best fundamentals on the EuroNext exchanges | Find the competitors with the best valuation on the EuroNext exchanges | Find the competitors with the best dividend on the EuroNext exchanges | Find the competitors with the best analyst ratings on the EuroNext exchanges
About SAN.PA
Company Profile
Sanofi engages in the research, production, and distribution of pharmaceutical products. The company is headquartered in Paris, Ile-De-France and currently employs 84,587 full-time employees. The company went IPO on 2002-07-01. The firm focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development, and production activities dedicated to vaccines. The CHC segment comprises the commercial operations for Sanofi’s Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Company’s products developed in collaboration or franchise include Dupixent, Aubagio, Lemtrada, Cerezyme, Lumizyme, Jevtana, Fabrazyme.
Company Info
SANOFI
46 Avenue de la Grande Armee
Paris ILE-DE-FRANCE FR
Employees: 82878
Phone: 33153774000
SANOFI / SAN.PA FAQ
Can you describe the business of SANOFI?
Sanofi engages in the research, production, and distribution of pharmaceutical products. The company is headquartered in Paris, Ile-De-France and currently employs 84,587 full-time employees. The company went IPO on 2002-07-01. The firm focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development, and production activities dedicated to vaccines. The CHC segment comprises the commercial operations for Sanofi’s Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Company’s products developed in collaboration or franchise include Dupixent, Aubagio, Lemtrada, Cerezyme, Lumizyme, Jevtana, Fabrazyme.
Can you provide the latest stock price for SANOFI?
The current stock price of SAN.PA is 80.36 EUR. The price decreased by -0.9% in the last trading session.
What is the dividend status of SANOFI?
SANOFI (SAN.PA) has a dividend yield of 5.08%. The yearly dividend amount is currently 3.79.
What is the ChartMill rating of SANOFI stock?
SAN.PA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
Can you provide the sector and industry classification for SANOFI?
SANOFI (SAN.PA) operates in the Health Care sector and the Pharmaceuticals industry.
What is the employee count for SAN stock?
SANOFI (SAN.PA) currently has 82878 employees.
What is the next earnings date for SAN stock?
SANOFI (SAN.PA) will report earnings on 2026-04-23.